See more : Kirin Holdings Company, Limited (KNBWY) Income Statement Analysis – Financial Results
Complete financial analysis of Jiangsu Hengrui Medicine Co., Ltd. (600276.SS) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Jiangsu Hengrui Medicine Co., Ltd., a leading company in the Drug Manufacturers – General industry within the Healthcare sector.
You may be interested
- KIOCL Limited (KIOCL.NS) Income Statement Analysis – Financial Results
- GoviEx Uranium Inc. (GXU.V) Income Statement Analysis – Financial Results
- byNordic Acquisition Corporation (BYNO) Income Statement Analysis – Financial Results
- Pakka Limited (PAKKA.BO) Income Statement Analysis – Financial Results
- Tech and Energy Transition Corporation (TETCU) Income Statement Analysis – Financial Results
Jiangsu Hengrui Medicine Co., Ltd. (600276.SS)
About Jiangsu Hengrui Medicine Co., Ltd.
Jiangsu Hengrui Medicine Co., Ltd., a pharmaceutical company, researches, develops, manufactures, and commercializes medicine worldwide. The company is developing Apatinib, Pyrotinib, Mecapegfilgrastim, SHR3680, SHR3162, SHR9549, SHR2554, SHR1459, SHR-1309, SHR-A1201, Camrelizumab, Famitinib, SHR-1316, SHR-1501, SHR-1603, SHR-1701, SHR-1702, and SHR-A1403 for oncology, metabolic, pain, autoimmune, and other indications. The company was founded in 1970 and is based in Lianyungang, China.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | 1997 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 22.82B | 21.28B | 25.91B | 27.73B | 23.29B | 17.42B | 13.84B | 11.09B | 9.32B | 7.45B | 6.20B | 5.44B | 4.55B | 3.74B | 3.03B | 2.39B | 1.96B | 1.42B | 1.18B | 1.15B | 1.05B | 756.03M | 634.27M | 484.71M | 413.93M | 363.79M | 303.57M |
| Cost of Revenue | 3.53B | 3.49B | 3.74B | 3.35B | 2.91B | 2.33B | 1.85B | 1.43B | 1.37B | 1.31B | 1.16B | 870.40M | 784.14M | 605.50M | 523.85M | 400.87M | 330.37M | 266.34M | 229.91M | 286.32M | 348.19M | 278.60M | 255.39M | 226.71M | 216.24M | 205.61M | 180.39M |
| Gross Profit | 19.29B | 17.79B | 22.16B | 24.39B | 20.38B | 15.08B | 11.99B | 9.66B | 7.94B | 6.14B | 5.04B | 4.56B | 3.77B | 3.14B | 2.51B | 1.99B | 1.63B | 1.16B | 949.35M | 858.82M | 702.16M | 477.43M | 378.88M | 258.00M | 197.69M | 158.18M | 123.18M |
| Gross Profit Ratio | 84.55% | 83.61% | 85.56% | 87.93% | 87.49% | 86.60% | 86.63% | 87.07% | 85.28% | 82.38% | 81.33% | 83.99% | 82.77% | 83.83% | 82.71% | 83.25% | 83.14% | 81.28% | 80.50% | 75.00% | 66.85% | 63.15% | 59.73% | 53.23% | 47.76% | 43.48% | 40.58% |
| Research & Development | 4.95B | 4.89B | 5.94B | 4.99B | 3.90B | 2.67B | 1.76B | 1.18B | 891.67M | 651.98M | 563.13M | 535.01M | 65.18M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 2.29B | 1.75B | 2.06B | 2.23B | 1.55B | 997.24M | 1.12B | 936.49M | 782.57M | 689.96M | 1.16B | 314.13M | 282.66M | 621.39M | 435.72M | 341.97M | 406.23M | 300.88M | 239.66M | 226.65M | 198.35M | 117.27M | 107.04M | 65.04M | 57.80M | 41.81M | 32.18M |
| Selling & Marketing | 7.58B | 7.35B | 9.38B | 9.80B | 8.52B | 6.46B | 5.19B | 4.35B | 3.52B | 2.84B | 2.35B | 2.34B | 1.91B | 1.60B | 1.35B | 965.44M | 798.09M | 562.56M | 476.00M | 430.68M | 339.86M | 234.07M | 168.59M | 111.79M | 66.93M | 55.58M | 47.03M |
| SG&A | 9.98B | 9.10B | 11.44B | 12.03B | 10.08B | 7.46B | 6.31B | 5.29B | 4.31B | 3.53B | 3.51B | 2.65B | 2.20B | 2.23B | 1.78B | 1.31B | 1.20B | 863.44M | 715.66M | 657.33M | 538.21M | 351.34M | 275.63M | 176.83M | 124.73M | 97.39M | 79.21M |
| Other Expenses | -584.85M | 458.68M | 697.90M | 888.69M | 717.72M | -97.57M | -48.63M | -9.33M | 9.38M | 27.52M | 31.43M | 46.56M | 32.65M | 14.99M | 8.97M | 20.31M | 3.82M | 544.12K | 6.12M | 2.70M | 14.54M | 2.13M | 9.69M | 12.59M | 683.27K | 4.12M | 13.21M |
| Operating Expenses | 14.38B | 14.44B | 18.08B | 17.91B | 14.69B | 10.84B | 8.24B | 6.82B | 5.52B | 4.44B | 3.62B | 3.33B | 2.73B | 2.28B | 1.83B | 1.35B | 1.24B | 886.05M | 734.84M | 674.89M | 551.59M | 360.62M | 283.44M | 181.83M | 128.91M | 100.51M | 81.53M |
| Cost & Expenses | 17.91B | 17.93B | 21.82B | 21.26B | 17.60B | 13.17B | 10.09B | 8.26B | 6.90B | 5.75B | 4.77B | 4.20B | 3.52B | 2.89B | 2.35B | 1.75B | 1.57B | 1.15B | 964.75M | 961.20M | 899.79M | 639.21M | 538.83M | 408.54M | 345.15M | 306.13M | 261.92M |
| Interest Income | 477.14M | 385.28M | 367.46M | 290.27M | 127.14M | 70.15M | 87.42M | 126.09M | 126.20M | 81.28M | 25.82M | 17.69M | 15.69M | 10.95M | 8.34M | -0.23 | -0.45 | 5.33M | 3.11M | 923.31K | 623.69K | 266.91K | 1.80M | 1.64M | -0.36 | -0.85 | -0.86 |
| Interest Expense | 6.66M | 6.49M | 4.71M | 5.49M | 6.88M | 4.78M | 36.63M | 1.87M | 30.00K | 94.70K | 30.00K | 52.92K | 60.92K | 0.00 | 0.00 | 4.67M | 3.90M | 4.66M | 2.84M | 12.88M | 17.18M | 12.58M | 12.18M | 7.37M | 6.74M | 9.27M | 10.07M |
| Depreciation & Amortization | 793.94M | 644.15M | 540.73M | 475.22M | 645.84M | 380.84M | 320.12M | 255.37M | 222.45M | 213.32M | 170.71M | 131.81M | 97.55M | 71.33M | 64.28M | 60.24M | 58.38M | 56.94M | 56.74M | 45.27M | 39.32M | 22.43M | 17.88M | 14.95M | 13.32M | 9.10M | 9.50M |
| EBITDA | 5.54B | 4.68B | 5.02B | 7.38B | 6.68B | 4.89B | 4.06B | 3.27B | 2.64B | 1.90B | 1.60B | 1.48B | 1.16B | 931.34M | 844.96M | 706.82M | 449.84M | 350.89M | 280.28M | 230.81M | 207.20M | 145.53M | 127.72M | 104.21M | 82.10M | 57.67M | 41.65M |
| EBITDA Ratio | 24.28% | 22.31% | 19.61% | 26.54% | 28.63% | 28.17% | 29.46% | 29.42% | 30.03% | 27.11% | 26.69% | 26.37% | 27.13% | 25.40% | 21.38% | 38.49% | 19.05% | 24.67% | 23.77% | 20.16% | 19.73% | 19.25% | 20.14% | 21.51% | 19.91% | 15.97% | 13.84% |
| Operating Income | 4.91B | 4.11B | 4.66B | 7.01B | 6.15B | 4.60B | 3.81B | 3.02B | 2.56B | 1.77B | 1.45B | 1.30B | 1.03B | 845.21M | 771.72M | 449.71M | 507.64M | 289.75M | 225.90M | 178.18M | 140.14M | 110.59M | 91.23M | 73.35M | 62.56M | 48.98M | 32.52M |
| Operating Income Ratio | 21.52% | 19.33% | 18.01% | 25.26% | 26.41% | 26.39% | 27.52% | 27.26% | 27.47% | 23.78% | 23.39% | 23.92% | 22.69% | 22.57% | 25.48% | 18.80% | 25.90% | 20.37% | 19.16% | 15.56% | 13.34% | 14.63% | 14.38% | 15.13% | 15.11% | 13.46% | 10.71% |
| Total Other Income/Expenses | -242.80M | -143.47M | -198.51M | -111.59M | -93.92M | -97.57M | -48.63M | -9.87M | 3.10M | 27.20M | 27.46M | 46.29M | 32.65M | 14.79M | 92.22M | -143.74M | 140.42M | -455.44K | -5.20M | -11.19M | 10.55M | -84.45K | 6.44M | 8.54M | 150.22K | 3.16M | 11.99M |
| Income Before Tax | 4.67B | 3.97B | 4.47B | 6.90B | 6.06B | 4.50B | 3.76B | 3.01B | 2.56B | 1.80B | 1.48B | 1.35B | 1.07B | 860.21M | 780.69M | 470.02M | 511.46M | 289.30M | 220.70M | 172.66M | 150.69M | 110.51M | 97.67M | 81.89M | 62.71M | 52.13M | 44.51M |
| Income Before Tax Ratio | 20.45% | 18.65% | 17.24% | 24.86% | 26.00% | 25.83% | 27.17% | 27.16% | 27.50% | 24.15% | 23.84% | 24.77% | 23.41% | 22.97% | 25.77% | 19.65% | 26.10% | 20.34% | 18.72% | 15.08% | 14.35% | 14.62% | 15.40% | 16.89% | 15.15% | 14.33% | 14.66% |
| Income Tax Expense | 389.29M | 153.42M | -17.72M | 586.59M | 729.31M | 437.90M | 466.24M | 378.99M | 338.00M | 226.72M | 186.48M | 195.09M | 124.64M | 104.77M | 87.39M | 34.43M | 92.93M | 84.39M | 60.63M | 51.34M | 58.49M | 31.24M | 16.26M | 16.35M | 11.06M | 8.49M | 3.38M |
| Net Income | 4.30B | 3.91B | 4.53B | 6.33B | 5.33B | 4.07B | 3.22B | 2.59B | 2.17B | 1.52B | 1.24B | 1.08B | 876.61M | 724.17M | 665.73M | 422.95M | 412.92M | 206.65M | 162.22M | 122.62M | 94.52M | 78.95M | 81.16M | 65.27M | 51.33M | 43.23M | 41.07M |
| Net Income Ratio | 18.85% | 18.36% | 17.49% | 22.82% | 22.88% | 23.34% | 23.25% | 23.34% | 23.31% | 20.34% | 19.96% | 19.82% | 19.26% | 19.34% | 21.98% | 17.68% | 21.07% | 14.53% | 13.76% | 10.71% | 9.00% | 10.44% | 12.80% | 13.47% | 12.40% | 11.88% | 13.53% |
| EPS | 0.68 | 0.61 | 0.71 | 1.00 | 0.84 | 0.64 | 0.50 | 0.41 | 0.34 | 0.24 | 0.20 | 0.17 | 0.14 | 0.12 | 0.11 | 0.07 | 0.07 | 0.03 | 0.02 | 0.02 | 0.01 | 0.01 | 0.01 | 0.01 | 0.02 | 0.01 | 0.01 |
| EPS Diluted | 0.68 | 0.61 | 0.71 | 1.00 | 0.84 | 0.63 | 0.50 | 0.41 | 0.34 | 0.24 | 0.20 | 0.17 | 0.14 | 0.12 | 0.11 | 0.07 | 0.07 | 0.03 | 0.02 | 0.02 | 0.01 | 0.01 | 0.01 | 0.01 | 0.02 | 0.01 | 0.01 |
| Weighted Avg Shares Out | 6.33B | 6.37B | 6.38B | 6.36B | 6.34B | 6.36B | 6.29B | 6.32B | 6.33B | 6.30B | 6.31B | 6.29B | 6.29B | 6.27B | 6.27B | 6.25B | 6.25B | 6.25B | 3.34B | 3.34B | 3.34B | 3.34B | 3.34B | 3.34B | 3.34B | 3.34B | 3.34B |
| Weighted Avg Shares Out (Dil) | 6.33B | 6.37B | 6.38B | 6.36B | 6.34B | 6.43B | 6.39B | 6.32B | 6.35B | 6.31B | 6.31B | 6.29B | 6.29B | 6.27B | 6.27B | 6.25B | 6.25B | 6.25B | 3.34B | 3.34B | 3.34B | 3.34B | 3.34B | 3.34B | 3.34B | 3.34B | 3.34B |
No news found for: 600276.SS
Source: https://incomestatements.info
Category: Stock Reports